Product Benefits:

• Improves glycemic control in adults with type 2 diabetes when diet & exercise alone are insufficient 

• Combines two modes of action: Empagliflozin helps excrete glucose via urine; Linagliptin enhances insulin secretion by inhibiting DPP-4

  Convenient once-daily tablet dosing (morning) with or without food 

• Helps reduce risks associated with high blood glucose in heart or kidney disease patients 

• Manufactured by Eskayef Pharmaceuticals in Bangladesh